New Delhi, November 07, 2015: Torrent Pharma, one of the leading pharma companies of the country has commenced commercial operations at its new plant in Dahej. This is the Company’s 5th formulation Plant and the 2nd API Plant. The facility is being set up in a two phases. The total investment made in the first phase of the plant is over Rs. 650 crores.
The new plant, situated in Dahej SEZ is spread across 70 acres site with a built up area of around 97000 sq. mtr. Phase I will have installed capacity of about 7,500 million tablets / capsules and 25 MT API per annum. The plant will cater mainly to the more regulated international markets such as US, Brazil, Germany etc. and is already approved / under approval by regulatory authorities of these countries.
Jinesh Shah, Executive Director at Torrent Pharma said, “This plant will scale up Torrent’s manufacturing capacity to meet the growing demand from the international markets.”
Construction of Phase II will commence soon and once commissioned the total capacity will increase to about 14,000 million tablets / capsules and 80 MT API per year.
- This specialized division empowers patients with neurological disorders to reclaim their mobility through a…
SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…
Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…
DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…
Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…
Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…